Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (481-490 of 1,061) with videos related to

Pageof 107
Sort By:
ESC Heart Failure|August 14, 2021
Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trialWilliam T Abraham, Daniel Bensimhon, Sean P Pinney, et al.
The Journal of Biological Chemistry|September 6, 2021
Collagen's primary structure determines collagen:HSP47 complex stoichiometryElena T Abraham, Sinan Oecal, Matthias Mörgelin, et al.
Journal of the American College of Cardiology|June 20, 2006
Beta-blocker use and outcomes among hospitalized heart failure patientsJaved Butler, James B Young, William T Abraham, et al.
Reviews in Cardiovascular Medicine|October 31, 2003
Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunctionGregg C Fonarow, William T Abraham, Christopher P Cannon, et al.
European Heart Journal|March 18, 2010
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodellingGeorg Fröhlich, Jan Steffel, David Hürlimann, et al.
The Journal of Biological Chemistry|August 16, 2000
Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodiesI Mothe-Satney, G J Brunn, L P McMahon, et al.
The Journal of Biological Chemistry|July 7, 1995
Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cellsA T Ting, C J Dick, R A Schoon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1984
Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitroR T Abraham, J E Knapp, M B Minnigh, et al.
JACC. Cardiovascular Imaging|July 8, 2009
Imaging cardiac resynchronization therapyTheodore Abraham, David Kass, Giovanni Tonti, et al.
American Heart Journal|October 18, 2008
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristicsWilliam T Abraham, Daniel Burkhoff, Koonlawee Nademanee, et al.
Pageof 107

Showing results (481-490 of 1,061) with videos related to

Sort By:
Pageof 107
ESC Heart Failure|August 14, 2021
Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trialWilliam T Abraham, Daniel Bensimhon, Sean P Pinney, et al.
The Journal of Biological Chemistry|September 6, 2021
Collagen's primary structure determines collagen:HSP47 complex stoichiometryElena T Abraham, Sinan Oecal, Matthias Mörgelin, et al.
Journal of the American College of Cardiology|June 20, 2006
Beta-blocker use and outcomes among hospitalized heart failure patientsJaved Butler, James B Young, William T Abraham, et al.
Reviews in Cardiovascular Medicine|October 31, 2003
Role of beta-blocker therapy in the post-myocardial infarction patient with and without left ventricular dysfunctionGregg C Fonarow, William T Abraham, Christopher P Cannon, et al.
European Heart Journal|March 18, 2010
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodellingGeorg Fröhlich, Jan Steffel, David Hürlimann, et al.
The Journal of Biological Chemistry|August 16, 2000
Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodiesI Mothe-Satney, G J Brunn, L P McMahon, et al.
The Journal of Biological Chemistry|July 7, 1995
Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cellsA T Ting, C J Dick, R A Schoon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1984
Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitroR T Abraham, J E Knapp, M B Minnigh, et al.
JACC. Cardiovascular Imaging|July 8, 2009
Imaging cardiac resynchronization therapyTheodore Abraham, David Kass, Giovanni Tonti, et al.
American Heart Journal|October 18, 2008
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristicsWilliam T Abraham, Daniel Burkhoff, Koonlawee Nademanee, et al.
Pageof 107